In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug Trastuzumab (Herceptin (Regd) ) is associated with prolonged survival but also increases the risk of developing heart problems, a new systematic review shows. However, the review, published in The Cochrane Library, concludes that more women benefit from use of Trastuzumab than are harmed. The review focuses on treatment for women with advanced stage breast cancer who ...Monday, 2 February 2015
Benefits of Breast Cancer Drug Trastuzumab Outweigh the Risk of Harm
In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug Trastuzumab (Herceptin (Regd) ) is associated with prolonged survival but also increases the risk of developing heart problems, a new systematic review shows. However, the review, published in The Cochrane Library, concludes that more women benefit from use of Trastuzumab than are harmed. The review focuses on treatment for women with advanced stage breast cancer who ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment